CIAS
UTHR icon

Capital Investment Advisory Services’s United Therapeutics UTHR Stock Holding History

Capital Investment Advisory Services’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$630K Hold
1,163
– – 0.04% 398
2026
Q1 		$690K Buy
1,163
+1
+0.1% +$498 0.05% 334
2025
Q4 		$566K Sell
1,162
-7
-0.6% -$3.26K 0.04% 360
2025
Q3 		$490K Sell
1,169
-5
-0.4% -$1.68K 0.04% 370
2025
Q2 		$337K Buy
1,174
+28
+2% +$8.37K 0.03% 427
2025
Q1 		$353K Sell
1,146
-96
-8% -$32.9K 0.03% 390
2024
Q4 		$438K Buy
1,242
+142
+13% +$52.2K 0.04% 313
2024
Q3 		$394K Buy
+1,100
New +$372K 0.04% 341

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Capital Investment Advisory Services's UTHR Position: Q2 2026 in Review

Capital Investment Advisory Services held its United Therapeutics (UTHR) position steady in Q2 2026 at 1,163 shares worth $630K. The position accounts for 0.04% of the portfolio, ranked #398.

Capital Investment Advisory Services first reported a position in UTHR in Q3 2024 and has held it in 8 quarters since. The position peaked at $690K in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Capital Investment Advisory Services held 1,163 shares of United Therapeutics worth $630K as of Q2 2026.
  • Capital Investment Advisory Services left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up 0.04% of Capital Investment Advisory Services's portfolio in Q2 2026, its #398 holding.
  • Capital Investment Advisory Services first reported a position in United Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • Capital Investment Advisory Services's United Therapeutics position peaked at $690K in Q1 2026.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Capital Investment Advisory Services's 13F filing for Q2 2026, filed 23 Jul 2026.